CAS: 82640-04-8; Raloxifene Hydrochloride

该化合物是选择性雌激素受体调节器(SERM),具有雌激素刺激和对立特性,用于治疗和预防绝经后妇女骨质疏松症,以及降低侵入性乳腺癌的风险. 它的独特机制提供了有针对性的治疗好处,减少了副作用.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号84449-63-8 2-[4-(乙酰氧基)苯基]苯... | CAS号84449-80-9 4-[2-(1-吡咯烷基)乙氧... | CAS号84541-36-6 [6-甲氧基-2-(4-甲氧基... | CAS号63675-74-1 6-甲氧基-2-(4-甲氧苯基)苯并噻吩 | CAS号84449-85-4 [6-[(methylsulf... | CAS号84449-90-1 雷洛昔芬 | CAS号15570-12-4 3-甲氧基苯硫酚 | CAS号166975-76-4 4-(2-哌啶乙氧基)苯甲酸盐酸盐 | CAS号63675-73-0 4-甲氧基-A-[(3-甲氧基... | CAS号2632-13-5 4-甲氧基-α-溴代苯乙酮 | CAS号84449-90-1 雷洛昔芬

合成工艺路线路线简述

  • 合成目标产物 Raloxifene Hydrochloride 主要起始原料 6-Methoxy-2-(4-Methoxy Phenyl)-Benzo[b]Thien-3-Yl][4-[2-(1-[piperidinyl)Ethoxy]Phenyl]Methanone Hydrochloride
  • 84541-36-6 = 82640-04-8
    反应条件:1.1 Reagents: Ethanethiol,Aluminum Chloride Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 15 Min,0 - 5 °C; 10 Min,0 - 5 °C1.2 Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 20 Min,0 - 5 °C; 3 H,Rt; Rt -> 0 °C1.3 Solvents: Tetrahydrofuran; 30 Min,0 - 5 °C1.4 Reagents: Water; 15 Min,Cooled1.5 Reagents: Hydrochloric Acid; 10 H,Rt
    标题:Expeditious Synthesis Of 3-Aryl Benzothiophene A Raloxifene Intermediate
    作者:Umareddy,Pailla; Et Al
    参考文献:Journal Of Chemical And Pharmaceutical Research 日期:2017 卷标:9(10) 页码:106-110]

    84449-80-9 + 63675-74-1 = 82640-04-8
    反应条件:1.1 Reagents: Thionyl Chloride Solvents: Dimethylformamide,Chlorobenzene; 2 H1.2 Reagents: Aluminum Chloride Solvents: Dichloromethane; 1.5 H,27 - 29 °C1.3 Reagents: Ethanethiol; 0.5 H,32 - 34 °C
    标题:Synthesis Of Raloxifene Hydrochloride As Selective Estrogen Receptor Modulator
    作者:Chen,Yanzhong; Et Al
    参考文献:Guangdong Yaoxueyuan Xuebao 日期:2002 卷标:18(1) 页码:1-3]

    84449-85-4 = 82640-04-8
    反应条件:1.1 Reagents: Potassium Hydroxide Solvents: Water; Rt -> 105 °C; 60 Min,102 - 105 °C; 105 °C -> 35 °C; 25 - 35 °C1.2 Solvents: Water; Ph 10 - 11,25 - 35 °C1.3 Solvents: Methanol,Water; Rt -> 70 °C; 45 Min,70 °C1.4 Reagents: Hydrochloric Acid Solvents: Water; 3 H,Ph 2,65 - 70 °C1.5 Solvents: Water; 60 Min,70 °C -> 5 °C; 0 - 5 °C
    标题:An Improved Synthesis Of Raloxifene Hydrochloride: A Selective Estrogen Receptor Modulator
    作者:Bathini,Pavan Kumar; Et Al
    参考文献:Heterocyclic Letters 日期:2014 卷标:4(4) 页码:515-518]

    84449-81-0 + 63675-74-1 = 82640-04-8
    反应条件:1.1 Reagents: Aluminum Chloride; 30 Min,Rt; Rt -> 30 °C; 2 H,25 - 35 °C1.2 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.3 Reagents: Hydrogen,Hydrochloric Acid Solvents: Methanol; 1 H,25 - 35 °C
    标题:Industrially Viable Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride
    作者:Chavakula,R.; Et Al
    参考文献:Organic Chemistry: An Indian Journal 日期:2018 卷标:14(3)]

    84449-90-1 = 82640-04-8
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Tetrahydrofuran
    标题:Synthesis Of Raloxifene Hydrochloride
    作者:Gong,Ping; Et Al
    参考文献:Shenyang Yaoke Daxue Xuebao 日期:2003 卷标:20(2) 页码:111-113]

    84449-80-9 + 63675-74-1 = 82640-04-8
    反应条件:1.1 Reagents: Thionyl Chloride Solvents: Dichloromethane; 15 - 30 Min,25 - 35 °C; 2 H,40 - 45 °C1.2 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 10 °C; 10 °C -> 30 °C; 2 H,25 - 35 °C1.3 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.4 Reagents: Hydrochloric Acid Solvents: Methanol,Water; 1 H,25 - 35 °C
    标题:A Green Process For Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride
    作者:Chavakula,Ramadas; Et Al
    参考文献:Journal Of The Indian Chemical Society 日期:2019 卷标:96(3) 页码:391-393]

    84449-80-9 + 63675-74-1 = 82640-04-8
    反应条件:1.1 Reagents: Chlorobenzene,Thionyl Chloride Solvents: Dimethylformamide,Dichloromethane,Pyridine; 25 - 35 °C; 2 H,40 - 45 °C1.2 Reagents: Aluminum Chloride; 30 Min,Rt; 2 H,25 - 35 °C1.3 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.4 Reagents: Hydrogen,Hydrochloric Acid Solvents: Methanol; 1 H,25 - 35 °C
    标题:Industrially Viable Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride
    作者:Chavakula,R.; Et Al
    参考文献:Organic Chemistry: An Indian Journal 日期:2018 卷标:14(3)]

    84449-81-0 + 63675-74-1 = 82640-04-8
    反应条件:1.1 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 10 °C; 10 °C -> 30 °C; 2 H,25 - 35 °C1.2 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.3 Reagents: Hydrochloric Acid Solvents: Methanol,Water; 1 H,25 - 35 °C
    标题:A Green Process For Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride
    作者:Chavakula,Ramadas; Et Al
    参考文献:Journal Of The Indian Chemical Society 日期:2019 卷标:96(3) 页码:391-393]

    1627905-24-1 = 82640-04-8
    反应条件:1.1 Solvents: Dimethylformamide; Rt; 4 H,80 - 85 °C2.1 Reagents: Ethanethiol,Aluminum Chloride Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 15 Min,0 - 5 °C; 10 Min,0 - 5 °C2.2 Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 20 Min,0 - 5 °C; 3 H,Rt; Rt -> 0 °C2.3 Solvents: Tetrahydrofuran; 30 Min,0 - 5 °C2.4 Reagents: Water; 15 Min,Cooled2.5 Reagents: Hydrochloric Acid; 10 H,Rt
    标题:Expeditious Synthesis Of 3-Aryl Benzothiophene A Raloxifene Intermediate
    作者:Umareddy,Pailla; Et Al
    参考文献:Journal Of Chemical And Pharmaceutical Research 日期:2017 卷标:9(10) 页码:106-110]

    170636-68-7 = 82640-04-8
    反应条件:1.1 Solvents: Dimethylformamide2.1 Reagents: Ethanethiol Catalysts: Aluminum Chloride Solvents: 1,2-Dichloroethane
    标题:Processes For Preparing 3-(Benzoyl)-2-(4-Hydroxyphenyl)Benzothiophenes
    参考文献:European Patent Organization
雷洛昔芬二甲基醚置于n,N-二乙基苯胺,乙硫醇体系中,用 二氯甲烷 作为反应溶剂,化学反应 2.0H,以92%的收率获得产物盐酸雷洛昔芬
参考文献:一种盐酸雷洛昔芬及其中间体的制备方法
标题:一种盐酸雷洛昔芬及其中间体的制备方法
摘要:本发明公开了一种盐酸雷洛昔芬及其中间体的制备方法,使1‑{4‑[2‑(哌啶‑1‑基)乙氧基]苯基}‑2‑(2‑巯基‑4‑甲氧基苯基)乙酮(中间体1)与4‑甲氧基苯甲酰卤制得盐酸雷洛昔芬前驱体(中间体2),脱甲基保护,与盐酸制成盐酸雷洛昔芬;中间体1由中间体3(1‑{4‑[2‑(哌啶‑1‑基)乙氧基]苯基}‑2‑(2‑苄硫基‑4‑甲氧基苯基)乙酮)在三氟乙酸中脱去苄基保护反应反应生成,使(3‑甲氧基苯基)苄基硫醚氧化反应生成亚砜化合物,然后与1‑[2‑(4‑乙炔基苯氧基)乙基]哌啶反应反应生成中间体3;本发明反应条件较温和,副反应少,收率高,同时所采用试剂原料更价廉且易回收易制备,适于工业化大规模生产.

海关参考信息

专利信息


专利号:US-6372945-B1
优先权日:1995-06-07
标 题 :Process for the synthesis of vinyl sulfoxides
发明人:AIKINS JAMES A; MILLER RANDAL SCOT; ZHANG TONY Y
权利人:LILLY CO ELI
摘要:The present invention is directed to a new process for the synthesis of vinyl sulfoxides, in particular diarylvinyl sulfoxides

专利号:US-5606076-A
优先权日:1995-06-07
标 题 :Process for the synthesis of benzo[b]thiophenes
发明人:AIKINS JAMES A; ZHANG TONY Y
权利人:LILLY CO ELI
摘要:The present invention is directed to a process for the synthesis of 2-arylbenzo[b]thiophenes.

专利号:US-5569772-A
优先权日:1995-06-07
标 题:Process for the synthesis of benzo[b]thiophenes
发明人:HOARD DAVID W; LUKE WAYNE D
权利人:LILLY CO ELI
摘要:The present invention is directed to a new process for the synthesis of 2-aryl benzo[b]thiophenes, and to novel intermediates therefor.

专利号:US-5606075-A
优先权日:1995-06-07
标 题:Process for the synthesis of benzo[b]thiophenes
发明人:HOARD DAVID W; LUKE WAYNE D
权利人:LILLY CO ELI
摘要:The present invention is directed to new processes for the synthesis of 2-aryl benzo[b]thiophenes.

专利号:WO-2017100796-A1
优先权日:2015-12-11
标 题 :Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
发明人:WONG CHI-HUEY; HSU TSUI-LING; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI
权利人:SINACA ACAD; WONG CHI-HUEY; HSU TSUI-LING
摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta- 4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for disgnostic and therapeutic uses.

专利号:US-2017283878-A1
优先权日:2015-12-11
标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING
权利人:ACADEMIA SINICA
摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.
济南宏方德医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hfdchem.com
电话: 531-88870908👤
📞济南宏方德医药科技有限公司 ⚠️参考联系方式

销售电话:531-88870908
邮箱:1599077382@qq.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
安徽峆一药业股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.heryipharma.com
电话: 0086 (550) 771-1888👤
📞安徽峆一药业股份有限公司 ⚠️参考联系方式

销售电话:0086 (550) 771-1888
邮箱:ceo@heryipharma.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东诚汇医药集团有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jnchsd.com
企业联系电话:0531-58897025-13589078718👤
📞山东诚汇医药集团有限公司 ⚠️参考联系方式
联系人:刘吉华
电话:0531-58897025-13589078718
手机:13589078718

邮箱:market@jnchsd.com
通信地址: 济南市高新技术开发区开拓路2350号
邮编: 250101
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市高新技术开发区开拓路2350号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Lee J, Kim J, Jeong C, Baek KH, Ha J. Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data. Curr Med Res Opin. 2024 Sep;40(9):1589-1596. doi: 10.1080/03007995.2024.2390649. Epub 2024 Aug 18. 16(6):e62997. doi: 10.7759/cureus.62997.
3: Kandel SE, Tooker BC, Lampe JN. Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1. J Biol Chem. 2024 Aug;300(8):107594. doi: 10.1016/j.jbc.2024.107594. Epub 2024 Jul 18.
4: Demirbaş AE, Mohsen F, Topan C, Karakaya M, Kütük N, Alkan A. The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model. Int J Oral Maxillofac Implants. 2024 Jun 21;(3):435-445. doi: 10.11607/jomi.10040.

合成参考文献


参考文献:10.1016/j.bbrc.2023.08.050
摘要:Ikeda Y, Davis MI, Sumita K, Zheng Y, Kofuji S, Sasaki M, Hirota Y, Pragani R, Shen M, Boxer MB, Takeuchi K, Senda T, Simeonov A, Sasaki AT. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 2023 Oct;679():116–21. doi: 10.1016/j.bbrc.2023.08.050.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知